细胞癌和巨细胞研究:一个文献计量分析 (2004-2023)
Dingtian Qi1, Haoxun Zhang, Feng Xiong
1Department of Urology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Medicine
|December 17, 2024
概括
这种图书统计分析揭示了细胞癌 (RCC) 和巨细胞研究的关键趋势. 未来的研究应侧重于免疫疗法耐药性和巨与免疫检查点抑制剂的相互作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 图书统计学 图书统计学
背景情况:
- 细胞癌 (RCC) 涉及巨细胞的研究正在迅速扩大.
- 了解这一领域不断发展的趋势对于推进癌症治疗至关重要.
研究的目的:
- 识别和可视化研究热点和RCC-巨相互作用的全球趋势,使用文献计量分析.
- 为指导未来的研究方向在瘤学这一关键领域.
主要方法:
- 对778篇关于RCC巨细胞的出版物的图书统计分析,来源于科学网络核心集合.
- 使用VOSviewer,Citespace和Bibliometrics平台可视化研究趋势和热点.
主要成果:
- 中国在出版量方面处于领先地位,而美国在引用方面处于领先地位.
- 瘤学期刊是主要的出版场所,引用率很高.
- 关键的研究热点包括预后,免疫疗法,瘤微环境和免疫透.
结论:
- RCC巨细胞研究是一个重要的和不断增长的领域.
- 多omics数据集成和用于预测建模的人工智能显示出很大的前景.
- 未来的研究应该优先考虑了解免疫检查点抑制剂的抵抗机制和巨细胞与免疫检查点抑制剂的相互作用.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K